Delivery Order SPE2DB20D3101-SPE2DB25FRUK9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 units under a firm fixed-price contract valued at $7,296.70. The award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count) under a firm fixed-price contract valued at $2,641.58. The award, issued on August 20, 2025, represents a non-competitive, non-set-aside delivery order with an ultimate completion date of August 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same city. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,665.16 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in 30-count units. This competitive delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, carries firm fixed pricing and represents no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) under a firm fixed-price contract valued at $8,071.20, with an ultimate completion date of August 12, 2025. This non-set-aside delivery order represents a competitively awarded procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units. This is a non-set-aside, competitively awarded delivery order with firm fixed price terms and a ceiling value of $1,134.57, with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Modafinil 100 mg tablets in 30-count packages. This competitively awarded, firm fixed-price contract has a ceiling value of $4,035.60 and an ultimate completion date of July 29, 2025. The order is being fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract has a ceiling value of $1,143.54 and carries an ultimate completion date of August 22, 2025. The contract represents a non-set-aside procurement and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,621.96 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) under a firm fixed price contract type. This award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Modafinil 100 mg tablets in 30-count packaging, with a ceiling value of $1,040.59. This non-set-aside, competitively awarded contract features firm fixed price pricing and has an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor and major pharmaceutical distributor providing...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Modafinil 100 mg tablets in 30-count packages, with a ceiling value of $4,827.61 and firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUK9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count packaging) under a firm fixed-price contract with a ceiling value of $6,993.90. The delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a non-competitive set-aside contract awarded to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion potential value through December 2026. The SPE2DX vehicle serves as a comprehensive global pharmaceutical support contract enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's role as a prime pharmaceutical vendor reflects the company's established capability to meet federal procurement requirements across multiple therapeutic domains and serve critical military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 9/4/25 |